Skip to main content
. 2019 Jun 17;216(8):1891–1903. doi: 10.1084/jem.20182238

Figure 5.

Figure 5.

Enhanced neurogenesis by CX3CL1-ct in transgenic mice. (A) Immunostaining of brain sections from BrdU pulse-labeled mice at P21 was performed using BrdU antibody. Scale bar, 30 µm. (B) Stereological quantification confirmed enhanced neurogenesis in the neurogenic niche of the SGZ of Tg-CX3cl1-ct/tTA mice. (C) Mice were BrdU-labeled starting at P11 for 5 d and then examined at 6 wk of age. Brain sections were fixed and costained with BrdU (red) and NeuN (green) antibodies. Scale bar, 30 μm. (D) Quantification of both BrdU-positive cells and mature neurons in granular cell layers in Tg-CX3cl1-ct/tTA mice and WT control littermates was conducted, and the results were plotted (n = 6 pairs; **, P < 0.01, Student’s t test). (E and F) Newly dividing cells in the SVZ were labeled for BrdU, marked with circles (E), and quantitatively compared from one in every six fixed sections (F; n = 4; ***, P < 0.001, Student’s t test). Error bars are ± SEM.